It is a chemicals public limited company based in Gwalior, Madhya Pradesh, India, established in 1986.
1986 | Gwalior, Madhya Pradesh, India | Under Process Of Striking OffShriphal Pharmaceuticals Limited, a under process of striking off public limited company, was established on 11 September 1986 in Gwalior, Madhya Pradesh, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U02423MP1986PLC003573. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹4.59 M.
It upholds a compliant status. Its leadership includes Dinesh Agarwal (Director), Rekha Sharma (Director), Ashok Kumar Gupta (Director). Past directors included Abhay Mishra, Sachin Garg, Sunil Singh Yadav. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at 46, Ravi Nagar, Gwalior, Madhya Pradesh, 474002.
U02423MP1986PLC003573
003573
11 September 1986
₹2.00 Cr
₹4.59 M
Roc Gwalior
Unlisted
Under Process Of Striking Off
Explore comprehensive insights into Shriphal Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dinesh Agarwal | Director | 30 Sep 2004 | Current |
| Rekha Sharma | Director | 02 Mar 2019 | Current |
| Ashok Kumar Gupta | Director | 14 May 2010 | Current |
| Mahesh Pratap Singh | Director | 14 May 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 May 2010 | Past |
| Pramod Abcsdd | Director | 14 May 2010 | Past |
| Pramod Abcsdd | Director | 02 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shriphal Pharmaceuticals Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2017, Shriphal Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shriphal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shriphal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shriphal Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shriphal Pharmaceuticals Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
The activity Shriphal Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Gwalior. was completed.
Rekha Sharma was appointed as a Director was appointed as a Director on 02 Mar 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
Ashok Kumar Gupta was appointed as a Director was appointed as a Director on 14 May 2010 & has been associated with this company since 15 years 6 months . was recorded as a recent event.
Mahesh Pratap Singh was appointed as a Director was appointed as a Director on 14 May 2010 & has been associated with this company since 15 years 6 months . was recorded as a recent event.
The activity Dinesh Agarwal was appointed as a Director was appointed as a Director on 30 Sep 2004 & has been associated with this company since 21 years 2 months . was completed.
The CIN of Shriphal Pharmaceuticals Limited is U02423MP1986PLC003573.
Shriphal Pharmaceuticals Limited is headquartered at 46, Ravi Nagar, Gwalior, Madhya Pradesh, 474002.
Shriphal Pharmaceuticals Limited was incorporated on 11 September 1986.
The current directors of Shriphal Pharmaceuticals Limited are
The primary industry of Shriphal Pharmaceuticals Limited is Manufacturing.
Shriphal Pharmaceuticals Limited is unlisted.
The authorized capital of Shriphal Pharmaceuticals Limited is ₹2.00 Cr, and the paid-up capital is ₹4.59 M.
The compliance status of Shriphal Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX